Hoff, R., V. P. Berardi, B. J. Weiblen, L. Mahoney-Trout, M. L. Mitchell, and G. F. Grady. 1988. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. New England Journal of Medicine 318(9):525–530.
Sahai, I., and D. Marsden. 2009. Newborn screening. Critical Reviews in Clinical Laboratory Sciences 46(2):55–82.
Skloot, R. 2010. The Immortal Life of Henrietta Lacks. New York: Crown.
Spliethoff, H. M., L. Tao, S. M. Shaver, K. M. Aldous, K. A. Pass, K. Kannan, and G. A. Eadon. 2008. Use of newborn screening program blood spots for exposure assessment: Declining levels of perfluorinated compounds in New York State infants. Environmental Science and Technology 42(14):5361–5367.
Therrell, B. L., W. H. Hannon, K. A. Pass, F. Lorey, C. Brokopp, J. Eckman, M. Glass. R. Heidenreich, S. Kinney, S. Kling, G. Landenburger, F. J. Meaney, E. R. B. McCabe, S. Panny, M. Schwartz, and E. Shapira. 1996. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the Council of Regional Networks for Genetic Services. Biochemistry and Molecular Medicine 57:116–124.
Wilcken, B., and V. Wiley. 2008. Newborn screening. Pathology 40(2):104–115.
Yarborough, M., K. Fryer-Edwards, G. Geller, and R. R. Sharp. 2009. Transforming the culture of biomedical research from compliance to trustworthiness: Insights from nonmedical sectors. Academic Medicine 84(4):472–477.